Current Issue
Browse IssuesVolume 4 | Issue 11
ISSN (Print): 2631-8385
ISSN (Online): 2631-8393
The batches shown in Table 1 of Targocid 200 mg powder for injection/infusion or oral solution are being recalled immediately by Sanofi UK. This is due to out of specification results for bacterial endotoxins, as confirmed by testing of retain samples. This problem was discovered after a medical adverse event in which four patients developed a high grade of fever within three hours of receiving vials from the impacted batches..